Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.
Olujohungbe
A
A
Cinkotai
K I
KI
Yardumian
A
A
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*; D018579:Patient Selection; D006113:United Kingdom
D000986:Antisickling Agents; D006918:Hydroxyurea